We investigated plasma levels of AD-relevant complement proteins (C1q, clusterin, sCR1, C1s, FH) in AD patients and controls, and assessed their prediction accuracy in diagnosing AD alongside AT(N) biomarkers. This evidence concerns the gene C1S and Alzheimer disease.